Non-rhabdomyosarcoma soft-tissue sarcoma.

Milgrom, Sarah A; Million, Lynn; Mandeville, Henry; Safwat, Akmal; Ermoian, Ralph P; Terezakis, Stephanie

Milgrom, Sarah A; Million, Lynn; Mandeville, Henry; Safwat, Akmal; Ermoian, Ralph P; Terezakis, Stephanie.

Afiliación

Milgrom SA; Department of Radiation Oncology, University of Colorado, Denver, Colorado.
Million L; Department of Radiation Oncology, Stanford University, Stanford, California.
Mandeville H; Department of Radiation Oncology, Royal Marsden Hospital, London, UK.
Safwat A; Department of Radiation Oncology, Aarhus University Hospital, Aarhus, Denmark.
Ermoian RP; Department of Radiation Oncology, University of Washington, Seattle, Washington.
Terezakis S; Department of Radiation Oncology, University of Minnesota, Minneapolis, Minnesota.

Pediatr Blood Cancer ; 68 Suppl 2: e28279, 2021 05.

Article en En | MEDLINE | ID: mdl-33818885

Asunto(s)

Sarcoma/terapia; Niño; Terapia Combinada; Humanos; Pronóstico; Sarcoma/patología; Tasa de Supervivencia

Palabras clave

COG; NRSTS; SIOP; chemotherapy; non-rhabdomyosarcoma soft-tissue sarcoma; pazopanib; radiation therapy; sarcoma; surgery

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sarcoma Tipo de estudio: Prognostic_studies Límite: Child / Humans Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google